Veradigm Inc.

OTCPK:MDRX Stock Report

Market Cap: US$517.7m

Veradigm Dividends and Buybacks

Dividend criteria checks 0/6

Veradigm does not have a record of paying a dividend.

Key information

n/a

Dividend yield

n/a

Buyback Yield

Total Shareholder Yieldn/a
Future Dividend Yield0%
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

Recent updates

Analysis Article Feb 28

Veradigm (NASDAQ:MDRX) Is Doing The Right Things To Multiply Its Share Price

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Analysis Article Nov 10

Veradigm (NASDAQ:MDRX) Might Have The Makings Of A Multi-Bagger

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...
Analysis Article Mar 06

Veradigm's (NASDAQ:MDRX) Returns On Capital Are Heading Higher

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Typically, we'll want to...
Analysis Article Feb 13

Is It Too Late To Consider Buying Veradigm Inc. (NASDAQ:MDRX)?

While Veradigm Inc. ( NASDAQ:MDRX ) might not be the most widely known stock at the moment, it saw significant share...
Analysis Article Jan 22

Veradigm Inc. (NASDAQ:MDRX) Shares Could Be 47% Below Their Intrinsic Value Estimate

Key Insights Veradigm's estimated fair value is US$35.1 based on 2 Stage Free Cash Flow to Equity Current share price...
Analysis Article Jan 04

These 4 Measures Indicate That Veradigm (NASDAQ:MDRX) Is Using Debt Reasonably Well

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article Dec 03

Returns Are Gaining Momentum At Allscripts Healthcare Solutions (NASDAQ:MDRX)

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...
Seeking Alpha Sep 28

Allscripts Healthcare reaffirms 2022 financial guidance; shares fall 2%

Allscripts Healthcare Solutions (NASDAQ:MDRX) reaffirmed its 2022 financial guidance, including $110M-$120M of free cash flow. Also, the company said its Veradigm data insights segment would have 6%-7% revenue growth and 10%-15% year-over-year adjusted EBITDA growth. During an investor day presentation earlier Wednesday, Allscripts (MDRX) management used the opportunity to showcase its competitive advantages and benefits for providers and payers. Despite the presentation, shares are down ~2% in Wednesday afternoon trading. Seeking Alpha's Quant Rating views Allscripts (MDRX) with high marks for profitability and momentum.
Analysis Article Sep 17

Should You Think About Buying Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Now?

Allscripts Healthcare Solutions, Inc. ( NASDAQ:MDRX ), is not the largest company out there, but it saw a double-digit...
Analysis Article Aug 24

Investors Will Want Allscripts Healthcare Solutions' (NASDAQ:MDRX) Growth In ROCE To Persist

What are the early trends we should look for to identify a stock that could multiply in value over the long term? In a...
Analysis Article Jul 31

We Think Allscripts Healthcare Solutions (NASDAQ:MDRX) Is Taking Some Risk With Its Debt

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if MDRX's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if MDRX's dividend payments have been increasing.


Dividend Yield vs Market

Veradigm Dividend Yield vs Market
How does MDRX dividend yield compare to the market?
SegmentDividend Yield
Company (MDRX)n/a
Market Bottom 25% (US)1.3%
Market Top 25% (US)4.2%
Industry Average (Healthcare Services)1.0%
Analyst forecast (MDRX) (up to 3 years)0%

Notable Dividend: Unable to evaluate MDRX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate MDRX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate MDRX's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as MDRX has not reported any payouts.


Discover strong dividend paying companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/08 21:22
End of Day Share Price 2026/07/08 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Veradigm Inc. is covered by 29 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jasper HellwegArgus Research Company
Matthew GillmorBaird
Lawrence MarshBarclays